Check out my blog on PharmExec.com today!

Recently CMS announced two decisions on access to prescription drugs in Medicaid – an innovative approach (that states have been asking for) was approved in Oklahoma, but the media has focused on the denial of a less innovative Massachusetts approach. I think it’s fascinating that the media has focused on the Massachusetts decision, when in reality the Oklahoma decision is quite notable and exciting because it shows the way for manufacturers and states to work together. Read more at PharmExec.com.